The development of oral medication for scabies, containing ivermectin, as a novel topical formulation offers advantages such as targeted delivery and reduced systemic exposure. These advancements in drug formulation technology enhance the effectiveness and safety of ivermectin-based treatments for conditions such as scabies and head lice infestations.